Quantcast

Latest Amidines Stories

2014-09-28 23:02:43

Wright & Schulte LLC Continues To Investigate Complaints That Janssen Pharmaceuticals Did Not Disclose The Lack of An Effective Means To Treat Uncontrolled Bleeding In Patients Taking Xarelto Columbus, OH (PRWEB) September 28, 2014 Wright & Schulte LLC has learned that a Xarelto bleeding lawsuit complaint was filed on behalf of a California woman who alleges that she suffered life-threatening bleeding as a result of taking the blood thinner medication. According to the Xarelto...

2014-09-15 08:29:35

-Direct Oral Anticoagulant Measurement, Automated on ACL TOP® Family of Hemostasis Testing Systems- BEDFORD, Mass., Sept. 15, 2014 /PRNewswire/ --Instrumentation Laboratory (IL) today announced the commercialization in Europe of their HemosIL Direct Thrombin Inhibitor (DTI) Assay. When used in conjunction with HemosIL Dabigatran Calibrators and Controls, this test offers an automated solution for the measurement of dabigatran, a direct oral anticoagulant (DOAC). The assay,...

2014-09-02 08:30:31

Patients at higher risk of kidney problems due to existing diabetes were also evaluated for the effects of warfarin on kidney function RIDGEFIELD, Conn., Sept. 2, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a new post-hoc sub-analysis of the pivotal phase III RE-LY® trial assessing renal function change in patients with non-valvular atrial fibrillation (NVAF) treated with Pradaxa® (dabigatran etexilate mesylate) compared to warfarin. The...

2014-08-25 08:27:31

Hot Line session presentations to feature renal function data from pivotal RE-LY® trial and global GLORIA(TM)-AF registry updates RIDGEFIELD, Conn., Aug. 25, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from nine company-sponsored Pradaxa® (dabigatran etexilate mesylate) studies will be presented at the European Society of Cardiology (ESC) Congress 2014, August 30 to September 3 in Barcelona, Spain. The abstracts will feature data about the use...

2014-08-21 23:03:25

The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered uncontrollable internal bleeding or other serious injuries allegedly due to their use of the blood thinner. New York, New York (PRWEB) August 21, 2014 Xarelto lawsuit (http://www.xareltolawsuitcenter.com/) filings that allege the blood thinner caused patients to suffer uncontrollable internal bleeding and other serious injuries continue to mount in U.S. courts, Bernstein Liebhard LLP reports. According to court...

2014-08-17 23:00:12

All Aspects Of Litigation Surrounding The Federal Pradaxa Lawsuits Alleging Boehringer Ingelheim's Blood Thinner Caused Serious Internal Bleeding Have Been Suspended Until Completion Of A Settlement Agreement Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 18, 2014 The attorneys at Wright & Schulte LLC note all matters within the Pradaxa lawsuit litigation were recently placed on hold while plaintiffs’ attorneys and Pradaxa manufacturer Boehringer Ingelheim...

2014-08-13 23:11:30

Thousands of Pradaxa Lawsuits Currently Pending in U.S. Courts Accuse Boehringer Ingelheim of Failing to Provide Adequate Warnings Regarding Medication’s Alleged Bleeding Side Effects New York NY (PRWEB) August 13, 2014 Pradaxa Lawsuit News: As Pradaxa lawsuits continue to move forward in U.S. courts, several new reports published in the British Medical Journal are raising new questions about the data used to garner regulatory approval of the blood thinner. Among other things, the...

2014-07-27 23:02:21

Reports of Xarelto Bleeding Mounts As Doctors Are Prescribing Xarelto Over Pradaxa and Seeing a Rise In Adverse Events While Xarelto Lawsuits Begin to be Filed Reports Wright & Schulte LLC Columbus, OH (PRWEB) July 27, 2014 The Institute of Safe Medication Practices (ISMP) Found that the number of serious adverse events such as Xarelto bleeding side-effects reported after the use of the Xarelto blood thinner has now out numbered the complaints filed for its competitor Pradaxa, notes...

2014-07-09 23:04:27

Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP, notes that Xarelto® is surpassing Pradaxa® in the number of reported adverse events, according to the Institute for Safe Medication Practices’ most recent Quarter Watch Report. The attorneys at Schlichter, Bogard & Denton, LLP are offering free and confidential case reviews to those who allege to have suffered serious bleeding events after using Xarelto®. St. Louis, MO (PRWEB) July 09, 2014 According to...

2014-06-05 23:01:35

A recent settlement announcement involving Pradaxa has been announced by the manufacture, Boehringer Ingelheim. Toledo, Ohio (PRWEB) June 05, 2014 Boehringer Ingelheim, the manufacturing company of the blood thinning drug Pradaxa, announced in May 2014 a $650 million settlement deal this week to settle approximately 4,000 state and federal lawsuits. Reported by TIME May 2014, Pradaxa was approved by the US Food and Drug Administration (FDA) in October 2010, Pradaxa is formulated for use...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.